<DOC>
	<DOCNO>NCT01550432</DOCNO>
	<brief_summary>The rationale potential role antioxidant prevention cardiovascular disease ( CVD ) remain strong despite disappointing result recent trial select antioxidant vitamin . Glutathione ( GSH ) one body 's powerful antioxidant agent surprising paucity data use interventional therapy . Glutathione , take orally , immediately broken constituent amino acid , cysteine one essential . Available cysteine critical determinant intracellular GSH concentration . N-acetyl cysteine ( NAC ) antioxidant supplement use provide source cysteine replete GSH level . By replenish endogenous glutathione , possible NAC would exert effect ( ) exogenous GSH . However , new delivery system , liposomal GSH , keep glutathione intact . In study , investigator propose match cysteine content NAC GSH compare effect two supplement , two different dos , marker inflammation oxidative stress .</brief_summary>
	<brief_title>Effects Glutathione ( Antioxidant ) N-Acetylcysteine Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>1 . Gender : Both woman men 2 . Age : &gt; = 18 year 3 . Ethnicity race : All ethnic racial background welcome 4 . Presence Metabolic Syndrome : As define ATP III National 5.Cholesterol Education program , metabolic syndrome diagnose presence least three follow , measure screen clinic visit : Central obesity measure waist circumference : Men : Greater 40 inch Women : Greater 35 inch Fasting blood triglyceride great equal 150 mg/dL Blood HDL cholesterol : Men : Less 40 mg/dL Women : Less 50 mg/dL Blood pressure great equal 130/85 mmHg Fasting glucose great equal 100 mg/dL 6.Planning available clinic visit bottle pickups 8 week study participation 7.Ability willingness give write informed consent 8.No know active psychiatric illness . 1 . Daily intake dietary supplement contain antioxidant omega3 FAs 2 . Fasting blood glucose &gt; 140 mg/dL 3 . Significant liver enzyme abnormality AST ALT 2 time upper limit normal and/or Bilirubin 50 % upper limit normal Renal disease measure baseline : Serum creatinine &gt; 1.30 mg/dL , Calculated creatinine clearance &lt; 71 mL/min 4 . Self report personal history : Clotting disorder Clinically significant atherosclerosis ( e.g. , CAD , PAD ) Malignant neoplasm Ongoing infection Inflammatory disease ( e.g. , rheumatoid arthritis ) 5 . Subjects currently receive follow medication ( self report ) : AntiInflammatory drug Lipid lower drug include statin Antihypertensive drug Anticoagulant drug 6 . Body Mass Index ( BMI ) great equal 40 . 7 . Pregnant Lactating 8 . Inability communicate effectively study personnel</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>